William R. Ringo, Director at FIVE PRIME THERAPEUTICS INC (FPRX), sold 500 shares at $51.07 ($26K) on 2017-01-03, disclosed to the SEC on 2017-01-03.
Scheduled sale ($26k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ASMB | SELL | 2018-06-01 | $42K | — | Filing → |
| ASMB | SELL | 2018-05-02 | $43K | — | Filing → |
| ASMB | SELL | 2018-04-02 | $49K | — | Filing → |